The NBT (nitroblue tetrazolium) reduction assay is used to –
**Core Concept**
The NBT reduction assay is a laboratory test used to assess the functioning of neutrophils, specifically their ability to produce superoxides. This assay is based on the principle of **oxidative burst**, where phagocytic cells like neutrophils produce reactive oxygen species (ROS) to kill ingested microbes. The **nitroblue tetrazolium** (NBT) dye is reduced by superoxides to formazan, which is blue and can be measured spectrophotometrically.
**Why the Correct Answer is Right**
The correct answer is related to measuring the respiratory burst of phagocytes, as the reduction of NBT to formazan is directly proportional to the amount of superoxide produced by the cells. This assay is useful in diagnosing chronic granulomatous disease (CGD), a condition characterized by the inability of phagocytic cells to produce superoxides due to defects in the **NADPH oxidase** complex.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because while NBT can be used in various assays, the specific use in question is more targeted.
**Option B:** Incorrect as it does not directly relate to the primary use of the NBT reduction assay.
**Option D:** Incorrect because, although related to immune function, it is not the primary purpose of the NBT reduction assay.
**Clinical Pearl / High-Yield Fact**
The NBT reduction assay is a critical tool for diagnosing **chronic granulomatous disease (CGD)**, highlighting the importance of oxidative burst in phagocytic function. Remember, patients with CGD are prone to recurrent infections due to their impaired ability to kill certain bacteria and fungi.
**Correct Answer:** D. measure the respiratory burst of phagocytes